Core Viewpoint - The announcement details the pledge of shares by the controlling shareholder, Jichuan Holdings, which holds a significant portion of the company's shares, and clarifies that this pledge will not adversely affect the company's operations or governance [1][4]. Group 1: Share Pledge Details - Jichuan Holdings pledged a total of 108,200,000 shares, which represents 25.96% of its holdings and 11.74% of the company's total share capital [2][3]. - The pledged shares include 43,000,000 shares with a pledge date starting from June 10, 2025, and ending on October 11, 2025, and 65,200,000 shares with a pledge date starting from June 10, 2025, and ending on October 10, 2025 [2][4]. Group 2: Impact on Company Operations - The share pledge will not have a significant impact on the company's main business, financing credit, financing costs, or ongoing operational capabilities [4]. - There will be no major changes in the company's governance structure, and the board members will remain unchanged as a result of this pledge [4]. - The pledge does not trigger any performance compensation obligations for the controlling shareholder [4].
济川药业: 湖北济川药业股份有限公司关于控股股东部分股份质押的公告
